Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sawsan Youssef

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood|July 12, 2007
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesisCatherine M Shachaf, Omar D Perez, Sawsan Youssef, et al.
Cell|May 3, 2025
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodiesJacob Glanville, Mark Bellin, Sergei Pletnev, et al.
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood|July 12, 2007
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesisCatherine M Shachaf, Omar D Perez, Sawsan Youssef, et al.
Cell|May 3, 2025
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodiesJacob Glanville, Mark Bellin, Sergei Pletnev, et al.
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 4